BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 38804275)

  • 1. Validation of the Absorption-Enhancing Ability of Oligoarginines Grafted onto a Backbone of Hyaluronic Acid through Animal Studies from Rodents to Primates.
    Yagi H; Tomono T; Abe K; Tsutsumi Y; Makabe M; Mitsuhashi H; Kimura T; Kobayashi H; Miyata K; Shigeno K; Sakuma S
    Mol Pharm; 2024 May; ():. PubMed ID: 38804275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquisition of absorption-enhancing abilities of cationic oligopeptides with short chain arginine residues through conjugation to hyaluronic acid.
    Tomono T; Yagi H; Kanemoto S; Ukawa M; Miyata K; Shigeno K; Sakuma S
    Int J Pharm; 2022 Mar; 616():121519. PubMed ID: 35093459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Cell-Penetrating Peptides Anchored to Polysaccharide Platforms Applied via Various Mucosal Routes as an Absorption Enhancer.
    Yagi H; Tomono T; Handa Y; Saito N; Ukawa M; Miyata K; Shigeno K; Sakuma S
    Mol Pharm; 2023 Jan; 20(1):303-313. PubMed ID: 36484773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal absorption of antibody drugs enhanced by cell-penetrating peptides anchored to a platform of polysaccharides.
    Tomono T; Yagi H; Igi R; Tabaru A; Fujimoto K; Enomoto K; Ukawa M; Miyata K; Shigeno K; Sakuma S
    Int J Pharm; 2023 Nov; 647():123499. PubMed ID: 37832700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal absorption enhancement of protein drugs independent to their chemical properties in the presence of hyaluronic acid modified with tetraglycine-L-octaarginine.
    Tomono T; Yagi H; Ukawa M; Ishizaki S; Miwa T; Nonomura M; Igi R; Kumagai H; Miyata K; Tobita E; Kobayashi H; Sakuma S
    Eur J Pharm Biopharm; 2020 Sep; 154():186-194. PubMed ID: 32681963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the Chemical Structures of Oligoarginines Conjugated to Biocompatible Polymers as a Mucosal Adjuvant on Antibody Induction in Nasal Cavities.
    Mohri K; Miyata K; Egawa T; Tanishita S; Endo R; Yagi H; Ukawa M; Ochiai K; Hiwatari KI; Tsubaki K; Shigeno K; Tobita E; Uto T; Baba M; Sakuma S
    Chem Pharm Bull (Tokyo); 2018; 66(4):375-381. PubMed ID: 29607903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable Hyaluronic Acid Modified with Tetraglycine-l-octaarginine as a Safe Adjuvant for Mucosal Vaccination.
    Ukawa M; Tanishita S; Yagi H; Yoshida Y; Tomono T; Shigeno K; Tobita E; Uto T; Baba M; Sakuma S
    Mol Pharm; 2019 Mar; 16(3):1105-1118. PubMed ID: 30715891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligoarginine-linked polymers as a new class of penetration enhancers.
    Sakuma S; Suita M; Masaoka Y; Kataoka M; Nakajima N; Shinkai N; Yamauchi H; Hiwatari K; Tachikawa H; Kimura R; Yamashita S
    J Control Release; 2010 Dec; 148(2):187-96. PubMed ID: 20800631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocompatible Polymers Modified with d-Octaarginine as an Absorption Enhancer for Nasal Peptide Delivery.
    Miyata K; Ukawa M; Mohri K; Fujii K; Yamada M; Tanishita S; Higashitarumi S; Ishizaki S; Kumagai H; Ochiai K; Hiwatari KI; Tsubaki K; Shigeno K; Tobita E; Kobayashi H; Sakuma S
    Bioconjug Chem; 2018 May; 29(5):1748-1755. PubMed ID: 29648441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of an oligoarginine peptide displaying rapid cell penetration for improved intestinal absorption].
    Takayama K
    Yakugaku Zasshi; 2014; 134(1):55-61. PubMed ID: 24389618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permeation characteristics of oligoarginine through intestinal epithelium and its usefulness for intestinal peptide drug delivery.
    Kamei N; Morishita M; Ehara J; Takayama K
    J Control Release; 2008 Oct; 131(2):94-9. PubMed ID: 18692532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Balance between Hydrophobicity/Aromaticity and Positively Charged Residues May Influence the Cell Penetration Ability.
    Soltész D; Szabó I; Bánóczi Z
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach using functional peptides for efficient intestinal absorption of insulin.
    Morishita M; Kamei N; Ehara J; Isowa K; Takayama K
    J Control Release; 2007 Apr; 118(2):177-84. PubMed ID: 17270307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct Drug Delivery of Low-Permeable Compounds to the Central Nervous System Via Intranasal Administration in Rats and Monkeys.
    Iwasaki S; Yamamoto S; Sano N; Tohyama K; Kosugi Y; Furuta A; Hamada T; Igari T; Fujioka Y; Hirabayashi H; Amano N
    Pharm Res; 2019 Apr; 36(5):76. PubMed ID: 30937626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical and biological investigations of beta-oligoarginines.
    Seebach D; Namoto K; Mahajan YR; Bindschädler P; Sustmann R; Kirsch M; Ryder NS; Weiss M; Sauer M; Roth C; Werner S; Beer HD; Munding C; Walde P; Voser M
    Chem Biodivers; 2004 Jan; 1(1):65-97. PubMed ID: 17191776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of cationic compounds as an absorption enhancer for nasal drug delivery.
    Natsume H; Iwata S; Ohtake K; Miyamoto M; Yamaguchi M; Hosoya K; Kobayashi D; Sugibayashi K; Morimoto Y
    Int J Pharm; 1999 Aug; 185(1):1-12. PubMed ID: 10425360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative estimation of drug permeation through nasal mucosa using in vitro membrane permeability across Calu-3 cell layers for predicting in vivo bioavailability after intranasal administration to rats.
    Inoue D; Furubayashi T; Tanaka A; Sakane T; Sugano K
    Eur J Pharm Biopharm; 2020 Apr; 149():145-153. PubMed ID: 32057906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of Intranasal Drug Delivery with Intravail
    Rabinowicz AL; Carrazana E; Maggio ET
    Drugs R D; 2021 Dec; 21(4):361-369. PubMed ID: 34435339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Transdermal Absorption of Hyaluronic Acid via Fusion with Pep-1 and a Hyaluronic Acid Binding Peptide.
    Yan LH; Zhang YJ; Hu HJ; Zhang C; Wang Y; Xu XT; Zhang TC; Su R; Luo XG
    Macromol Biosci; 2023 Mar; 23(3):e2200173. PubMed ID: 36448643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.